Application 062117

Type
ANDA
Sponsor
FACTA FARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CEPHALEXINCEPHALEXINFOR SUSPENSION;ORALEQ 100MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons*NoNo
002CEPHALEXINCEPHALEXINFOR SUSPENSION;ORALEQ 125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons*NoNo
003CEPHALEXINCEPHALEXINFOR SUSPENSION;ORALEQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons*NoNo